Comorbid anxiety is associated with more changes in the Management of Postural Orthostatic Tachycardia Syndrome

Gen Hosp Psychiatry. 2024 Mar-Apr:87:1-6. doi: 10.1016/j.genhosppsych.2024.01.003. Epub 2024 Jan 11.

Abstract

Objective: Postural Orthostatic Tachycardia Syndrome (POTS) is not an anxiety disorder, but it shares similar symptomatology. The impact of this comorbidity on management is unknown. This information may lead to better strategies to improve the care of this subgroup.

Method: The electronic medical records of 322 patients seen at our institution between 2018 and 2022 with confirmed POTS diagnoses were analyzed. Demographics, anxiety comorbidities, questionnaire responses, and treatment course changes were collected. Negative binomial regression models examined if the presence of an anxiety disorder was associated with the number of POTS treatment course changes offset by observation time.

Results: When adjusted for sex, age, baseline GAD-7 score, and baseline PROMIS global mental health score, those with a diagnosis of an anxiety disorder had2.6 times the incident rate of treatment changes for POTS management (IRR = 2.66 (95% CI: 1.43-4.95)).

Conclusion: Individuals carrying the diagnosis of an anxiety disorder had an increase in the incident rate of treatment changes for POTS therapy. This finding may be due to the underlying pathophysiology and treatment of anxiety disorders, the effect of bias, and difficulty with symptom differentiation. More work needs to be done to determine how to best care for POTS patients with comorbid anxiety.

Keywords: Anxiety(2); Autonomic(4); POTS(1); Tachycardia(5); Treatment(3).

MeSH terms

  • Anxiety / epidemiology
  • Anxiety / therapy
  • Anxiety Disorders / epidemiology
  • Anxiety Disorders / therapy
  • Comorbidity
  • Humans
  • Postural Orthostatic Tachycardia Syndrome* / diagnosis
  • Postural Orthostatic Tachycardia Syndrome* / epidemiology
  • Postural Orthostatic Tachycardia Syndrome* / therapy